No Data
Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation
MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development
Express News | Mira Pharmaceuticals Inc - Submits Ind Application to FDA for Ketamir-2
Express News | Mira Pharmaceuticals Inc: Submission of Investigational New Drug (Ind) Application by End of 2024
Express News | EXCLUSIVE: Mira Pharmaceuticals Tells Benzinga 'Advancing Ketamir-2 Into Clinical Trials as Quickly as Possible Reflects Our Strategic Focus on Generating Proof-of-concept Data That Positions MIRA for a Potential M&A Transaction or Strategic Partnership'
EXCLUSIVE: MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile, Paving Way For Human Trials In Neuropathic Pain
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
, charts looking good, very possible
151158967 : Thank you, @Jaguar8 . Your hard work is appreciated!
103687630 : I think, what do you think of ONDS? There was good news on Wednesday but it went down. Do you think there is a chance for a rebound?
Jaguar8 OP 103687630 : I didn’t choose it because it didn’t specify how much is the contract.
103687630 Jaguar8 OP : Okay, thank you for your reply
70761249 : Can VERI make a breakthrough in the short term? The recent wildfires in Southern California are really heartbreaking, causing significant disappointment in the credibility of the media and government.
View more comments...